Twitter: Follow @HMSbioethics on Twitter and join the conversation using #neuroethx
Be notified of the next event: http://bit.ly/1IswvA9

About this Seminar

If a neurosurgeon develops a new technique, when can it be considered innovation, and when should it be considered investigation? How novel must the technique be, before specific consent is required from the patient? When should regulatory authorities review the technique?

We discussed these questions and more with two neurosurgeons experienced in innovation, bioethics, the law, and international regulation.

Speakers

Introduction

Thomas I. Cochrane, MD, MBA
Associate Neurologist and Senior Ethics Consultant, Brigham and Women’s Hospital
Assistant Professor of Neurology and Director of Neuroethics, Center for Bioethics, Harvard Medical School

Panel

Joseph Madsen, MD
Director, Epilepsy Surgery
Children's Hospital Boston

Marieke Broekman MD, PhD, JD
Neurosurgery, University Medical Center Utrecht